Currently, studies are underway to evaluate the role of metformin in preventing cancers in individuals with Li Fraumeni syndrome (caused by germline TP53 mutations) (Dixon‐Zegeye et al. The gene discussed is TP53; the disease is Li-Fraumeni syndrome.